F-8-F-amide,
F-8-F-NH2,
F8Famide,
FF8 (morphine modulating peptide),
FLFQPQRF-NH2,
FMRFamide-like octapeptide,
morphine modulating neuropeptide,
neuropeptide FF,
NPFF,
octapeptide F8FA,
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,
phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,
Neuropeptide FF,
99566-27-5,
CHEMBL429731,
MFCD00076704,
phe-leu-phe-gln-pro-gln-arg-phe-amide,
F-8-F-NH2,
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe amide,
PrRP31,
BDBM86139,
BDBM50037557,
AKOS024457451,
NCGC00167257-01,
CAS_99566-27-5,
B5386,
CAS_235433-36-0,
NEUROPEPTIDE FF MORPHINE MODULATING NEUROPEPTIDE,
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe amide, >=95% (HPLC),
2-{[1-(2-{2-[2-(2-Amino-3-phenyl-propionylamino)-4-methyl-pentanoylamino]-3-phenyl-propionylamino}-4-carbamoyl-butyryl)-pyrrolidine-2-carbonyl]-amino}-pentanedioic acid 5-amide 1-{[1-(1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butyl]-amide},
F8Famide,
Flfqpqrf-NH2,
Octapeptide F8FA,
NPFF,
NPSF,
F-8-F-Amide,
Fmrfamide-like octapeptide,
NSC_0,
Morphine modulating neuropeptide,
Phe-leu-phe-gln-pro-gln-arg-phe-NH2,
FF8 (Morphine modulating peptide),
C54H76N14O10,
CID9854861,
C54-H76-N14-O10,
phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,